Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Historical mysteries solved by science in 2025 - 2Former United Launch Alliance CEO Tory Bruno joins competitor Blue Origin for national security projects
- 3Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- 4Step by step instructions to Prepare with Senior Protection for Inward feeling of harmony.
- 5Why the weirdest sea level changes on Earth are happening off the coast of Japan
- Vote In favor of Your Favored Video Conferencing Administration
- Flat Earth, spirits and conspiracy theories – experience can shape even extraordinary beliefs
- Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
- Space Condos to Lift Your Metropolitan Living
- Photos of amputees in Gaza, struggling to survive after losing limbs to Israeli airstrikes
- Fossils unearthed in Morocco are first from little-understood period of human evolution
- Vote In favor of Your Favored Language Interpretation Administration
- Burkina Faso must 'forget' about democracy, military leader says
- Watch China's Shenzhou 22 rescue ship arrive at Tiangong space station (video)
